Leucine
PrivateLast Round
Series A
Oct 16, 2023
Est. Valuation
$3.2M
Total Funding Raised
$7.77M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Leucine operates in Enterprise Software and is based in Wilmington, Delaware. Its latest recorded funding round was a Series A round in October 2023.
Leucine is a software company that provides an AI-powered platform to help pharmaceutical manufacturers digitize workflows, ensure regulatory compliance, and improve operational efficiency.
Sector
Enterprise Software
Verticals
Quality Management, Smart Manufacturing, Compliance, Vertical SaaS, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Leucine Comparables
Compare Leucine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apprentice | 86% | |
| Aizon | 84% | |
| AmpleLogic | 83% |
For institutional investors. Book with your work email.
Leucine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 16, 2023 | ||||
| Seed | Jun 1, 2020 | ||||
| Accelerator | May 2, 2019 |
For institutional investors. Book with your work email.
Leucine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Seed, Series A, Accelerator |
| Axilor Ventures | Seed, Series A |
| Pravega Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 77% MoM, reaching 17K.
- Jul 5, 2026
Reached over 60 pharmaceutical enterprises as customers.
For institutional investors. Book with your work email.
Leucine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Leucine's valuation, stock price, and market status.
Is Leucine a public or private company?
Leucine is a private company.
What is the current stock price of Leucine?
Leucine is a private company, so its shares have no public market price. Caplight tracks Leucine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Leucine worth (valuation)?
Leucine's valuation is estimated at $3.2M based on funding round data.
Can I buy Leucine stock?
Leucine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Leucine's last funding round?
Leucine's most recent funding round was Series A on October 16, 2023.
Who are the main investors in Leucine?
Key investors in Leucine include Techstars, Pravega Ventures.
Will Leucine IPO soon?
No public IPO plans have been announced for Leucine.
How can I track Leucine secondary market activity?
Caplight tracks bids, offers, and trades in Leucine's shares on secondary markets.